Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
NCT05787522 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2026-02-12
Summary
The goal of this clinical trial is to evaluate performance and clinical applicability of AI-assisted radiotherapy contouring software (iCurveE) for thoracic organs at risk. The main question it aims to answer is:
• Does AI-assisted contouring (AI contouring with manual modification) offer greater accuracy and time efficiency compared to manual contouring? After screening, the qualified participants' thoracic CT images will be anonymized and segmented using three methods: manual, AI (AI-only), and AI-assisted contouring. The researchers will compare the results generated by the three different contouring methods with the ground truth established by expert consensus, in order to evaluate both accuracy and time-related parameters
Conditions
- Lung Cancer
- Breast Cancer
- Esophageal Cancer
Sponsors & Collaborators
-
Guangzhou Perception Vision Medical Technology Co. Ltd
collaborator UNKNOWN -
People's Hospital of Guangxi Zhuang Autonomous Region
collaborator OTHER -
Shanxi Province Cancer Hospital
collaborator OTHER -
Fifth Affiliated Hospital, Sun Yat-Sen University
collaborator OTHER -
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
collaborator OTHER -
Tianjin Medical University Cancer Institute and Hospital
lead OTHER
Principal Investigators
-
Zhiyong Yuan, Ph.D. · Tianjin Medical University Cancer Institute and Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-30
- Primary Completion
- 2023-07-27
- Completion
- 2024-03-06
Countries
- China
Study Locations
More Related Trials
-
Safety and Efficacy of SBRT in the Treatment of Thoracic Malignant Tumors at Different Sites
NCT05349552 ·Status: RECRUITING
-
Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors
NCT06587022 ·Status: RECRUITING
-
Prospective Study of Particle Radiotherapy for Breast Cancer With Different Arm Position
NCT05878678 ·Status: UNKNOWN ·Phase: PHASE2
-
Stereotactic Body Radio Therapy (SBRT) for Early-stage Non Small Cell Lung Cancer (NSCLC)
NCT00870116 ·Status: UNKNOWN ·Phase: NA
-
Tumor Response in Hypofractionated Radiotherapy
NCT02854449 ·Status: UNKNOWN
-
Hypofractionated vs. Conventionally Fractionated Concurrent CRT for Unresectable Stage III NSCLC
NCT03331575 ·Status: UNKNOWN ·Phase: PHASE3
-
3DV+TPS Software Outlines the Radiotherapy of Nasopharyngeal Carcinoma
NCT03810274 ·Status: COMPLETED
-
Stereotactic Radiotherapy With Different Fractionation Modes for the Early Lung Cancer
NCT05802641 ·Status: UNKNOWN
-
RT for Adenocarcinoma/Adenosquamous Carcinoma
NCT07153952 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Biomarkers for Prediction of Tumor Response to Radiotherapy
NCT03744819 ·Status: RECRUITING
-
Stereotactic Body Radiation Therapy (SBRT) in Newly Diagnosed Advanced Staged Lung Adenocarcinoma (Sindas)
NCT02893332 ·Status: TERMINATED ·Phase: PHASE3
-
Feasibility, Safety, and Efficacy of Stereotactic MRI-Guided Adaptive Radiation Therapy (SMART) for Central Lung Tumors
NCT05609331 ·Status: TERMINATED ·Phase: NA
-
Markerless Image Guidance Using Intrafraction Kolovoltage X-ray Imaging for Lung Cancer Radiotherapy
NCT04310891 ·Status: ACTIVE_NOT_RECRUITING
-
Stereotactic Radiotherapy and Image-guided Intensity Modulated Radiotherapy for Spinal Metastatic Tumors
NCT03963713 ·Status: UNKNOWN ·Phase: NA
-
Image-Guided Functional Lung Avoidance Thoracic Radiotherapy for Lung Cancer: A Single-Blind Randomized Trial
NCT03077854 ·Status: UNKNOWN ·Phase: NA
-
Deep Learning-based Classification and Prediction of Radiation Dermatitis in Head and Neck Patients
NCT05607225 ·Status: UNKNOWN
-
Toward High Fidelity Adaptive Radiotherapy in the Thorax
NCT04731571 ·Status: COMPLETED
-
Stereotactic Volumetric Radiotherapy in Prostate Cancer
NCT02423889 ·Status: COMPLETED ·Phase: PHASE2
-
Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung Cancer
NCT05802654 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study
NCT05802186 ·Status: RECRUITING ·Phase: NA
-
Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer
NCT02975609 ·Status: UNKNOWN ·Phase: PHASE2
-
Target Volume Delineation After NACT in LA-NPCarcinoma Patients Treated With NACT+ CCRT
NCT03283293 ·Status: COMPLETED ·Phase: PHASE2
-
Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy
NCT07014202 ·Status: RECRUITING ·Phase: PHASE2
-
Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal Injury
NCT00631839 ·Status: UNKNOWN
-
A Prospective, Randomized, Multicenter Clinical Study Comparing Adjuvant Radiotherapy Versus Observation in High-risk Localized Adrenocortical Carcinoma After Surgery.
NCT07141147 ·Status: NOT_YET_RECRUITING ·Phase: NA